Influence of Cytogenetics in Patients with Relapsed and Refractory Multiple Myeloma (MM) Treated with Carfilzomib (CFZ).

被引：0

作者：

Jakubowiak, Andrzej ^{[1
]}

Wang, Luhua ^{[2
]}

Orlowski, Robert Z. ^{[3
]}

Jagannath, Sundar ^{[4
]}

Siegel, David ^{[5
]}

Stewart, A. Keith ^{[6
]}

Kukreti, Vishal ^{[7
]}

Lonial, Sagar ^{[8
]}

McDonagh, Kevin T. ^{[9
]}

Vallone, Marcy ^{[10
]}

Kauffman, Michael ^{[10
]}

Vij, Ravi ^{[11
]}

机构：

[1] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

[2] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[4] St Vincent Catholic Med Ctr, New York, NY USA

[5] Hackensack Univ, Med Ctr, Hackensack, NJ USA

[6] Mayo Clin, Scottsdale, AZ USA

[7] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada

[8] Emory Univ, Sch Med, Atlanta, GA USA

[9] Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY USA

[10] Proteolix Inc, San Francisco, CA USA

[11] Washington Univ, Sch Med, St Louis, MO USA

[12] Multiple Myeloma Res Consortium, Norwalk, CT USA

来源：

BLOOD | 2009年 / 114卷 / 22期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：725 / 726

页数：2

共 50 条

[1] RESPONSES TO SINGLE-AGENT CARFILZOMIB (CFZ) ARE NOT AFFECTED BY CYTOGENETICS IN PATIENTS (PTS) WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA (R/R MM)
Jakubowiak, A. J.
Martin, T.
Singhal, S.
Wang, M.
Vij, R.
Jagannath, S.
Lonial, S.
Kukreti, V.
Buadi, F.
Kunkel, L.
Bray, L.
Vallone, M.
Orlowski, R. Z.
Siegel, D. S.
[J]. ANNALS OF ONCOLOGY, 2011, 22 : 122 - 122
[2] A phase I/II study of the combination of panobinostat (PAN) and carfilzomib (CFZ) in patients (pts) with relapsed or relapsed/refractory multiple myeloma (MM).
Berdeja, Jesus G.
Gregory, Tara K.
Matous, Jeffrey
Hart, Lowell L.
Owera, Rami
Mace, Joseph Ronald
Essell, James H.
Flinn, Ian
Faber, Edward Anthony
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[3] Responses and Survival Are Not Affected by Cytogenetics In Patients with Relapsed and Refractory Multiple Myeloma (R/R MM) Treated with Single-Agent Carfilzomib
Jakubowiak, Andrzej J.
Martin, Thomas
Singhal, Seema B.
Wang, Michael
Vij, Ravi
Jagannath, Sundar
Lonial, Sagar
Kukreti, Vishal
Buadi, Francis
Bray, Lauren
Vallone, Marcy
Kauffman, Michael
Orlowski, Robert Z.
Siegel, David Samuel diCapua
[J]. BLOOD, 2010, 116 (21) : 809 - 809
[4] Cardiac complications in relapsed and refractory multiple myeloma patients treated with carfilzomib
S Atrash
A Tullos
S Panozzo
M Bhutani
F Van Rhee
B Barlogie
S Z Usmani
[J]. Blood Cancer Journal, 2015, 5 : e272 - e272
[5] Cardiac complications in relapsed and refractory multiple myeloma patients treated with carfilzomib
Atrash, S.
Tullos, A.
Panozzo, S.
Bhutani, M.
Van Rhee, F.
Barlogie, B.
Usmani, S. Z.
[J]. BLOOD CANCER JOURNAL, 2015, 5 : e272 - e272
[6] Pooled Safety Analysis From Phase (Ph) 1 and 2 Studies of Carfilzomib (CFZ) In Patients With Relapsed and/or Refractory Multiple Myeloma (MM)
Singhal, Seema B.
Siegel, David Samuel diCapua
Martin, Thomas
Vij, Ravi
Wang, Michael
Jakubowiak, Andrzej J.
Lonial, Sagar
Kukreti, Vishal
Zonder, Jeffrey A.
Wong, Alvin F.
McCulloch, Leanne
Kauffman, Michael
Badros, Ashraf Z.
Niesvizky, Ruben
Orlowski, Robert Z.
Stewart, A. Keith
Jagannath, Sundar
[J]. BLOOD, 2010, 116 (21) : 814 - 815
[7] Discovery and development of carfilzomib (CFZ) for multiple myeloma (MM)
Wang, Zhengping
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
[8] Long-Term Treatment and Tolerability of the Novel Proteasome Inhibitor Carfilzomib (CFZ) In Patients with Relapsed and/or Refractory Multiple Myeloma (R/R MM)
Jagannath, Sundar
Vij, Ravi
Kaufman, Jonathan L.
Martin, Thomas
Niesvizky, Ruben
Gabrail, Nashat Y.
Alsina, Melissa
Wong, Alvin F.
Le, Mai H.
McCulloch, Leanne
Hannah, Alison L.
Kauffman, Michael
Siegel, David Samuel diCapua
[J]. BLOOD, 2010, 116 (21) : 814 - 814
[9] Peripheral Neuropathy Experience in Patients With Relapsed and/or Refractory Multiple Myeloma Treated With Carfilzomib
Martin, Thomas G.
[J]. ONCOLOGY-NEW YORK, 2013, 27 : 4 - 10
[10] Carfilzomib In Relapsed, or Relapsed and Refractory, Multiple Myeloma
McCormack, Paul L.
[J]. DRUGS, 2012, 72 (15) : 2023 - 2032

← 1 2 3 4 5 →